CELK AB Share Price Nasdaq Stockholm
Equities
SE0009189657
Advanced Medical Equipment & Technology
Sales 2024 * | 2.43B 229M 0 18.11B | Sales 2025 * | 2.78B 262M 0 20.71B | Capitalization | 3.1B 293M 0 23.14B |
---|---|---|---|---|---|
Net income 2024 * | -74M -6.98M - -552M | Net income 2025 * | -16M -1.51M - -119M | EV / Sales 2024 * | 1.02 x |
Net cash position 2024 * | 630M 59.45M 0 4.7B | Net cash position 2025 * | 311M 29.32M 0 2.32B | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
-41.5
x | P/E ratio 2025 * |
-191
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.54% |
Latest transcript on CELK AB
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 11-19 | |
Director of Finance/CFO | 39 | 30/11/21 | |
Marius Balger
COO | Chief Operating Officer | 56 | 28/02/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
CHM | Chairman | 79 | 25/04/22 |
John Mackay
BRD | Director/Board Member | 62 | 31/12/22 |
Director/Board Member | 68 | 17/12/19 |
1st Jan change | Capi. | |
---|---|---|
+4.80% | 213B | |
+9.00% | 188B | |
+30.54% | 157B | |
+32.91% | 113B | |
+4.60% | 64.85B | |
+21.80% | 55.17B | |
+1.34% | 49.1B | |
-4.89% | 38.83B | |
+1.58% | 35.6B |